Search for Clinical Trial Results

Sponsored By

Sarcoma, Clear Cell - 20 Studies Found

Status Study
Not yet recruiting Study Name: QUILT-3.031: AMG 337 in Subjects With Advanced or Metastatic Clear Cell Sarcoma
Condition: Clear Cell Sarcoma
Date: 2017-04-20
Interventions: Drug: AMG 337 6-{(1R)-1-[8-fluoro-6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl}-
Not yet recruiting Study Name: Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney
Condition: Kidney Cancer
Date: 2001-10-11
Interventions:
  • Biological: dactinomycin
  • Drug: carboplatin
Active, not recruiting Study Name: Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV Melanoma
Condition:
  • Sarcoma, Clear Cell
  • Sarcoma, Alveolar Soft Part
  • Date: 2005-11-23
    Interventions: Biological: GVAX 4 vaccines every two weeks
Completed Study Name: Phase 2 Study in Patients With MiT Tumors
Condition:
  • Renal Cell Carcinoma (RCC)
  • Alveolar Soft Part Sarcoma (ASPS)
  • Clear Cell Sarcoma of the Kidney
  • Recurrent Renal Cell Carcinoma
    Date: 2010-02-01
    Interventions:
    • Drug: Dalteparin Given SC
Recruiting Study Name: Induction Therapy With Vemurafenib and Cobimetinib to Optimize Nivolumab and Ipilimumab Therapy
Condition: Melanoma, Malignant, of Soft Parts
Date: 2016-11-11
Interventions: Drug: Vemurafenib and Cobimetinib Combination of Vemurafenib with Cobimetinib in BRAF V600E/K mutated me
Completed Study Name: Biomarkers in Tissue Samples From Patients With High-Risk Wilms Tumor
Condition:
  • Clear Cell Sarcoma of the Kidney
  • Recurrent Wilms Tumor and Othe
    Date: 2010-05-05
    Interventions:
    • Genetic: DNA methylation analysis

Completed Study Name: Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery
Condition:
  • Bone Cancer
  • Chondrosarcoma
  • Clear Cel
    Date: 2012-03-09
    Interventions:
    • Drug: therapeutic angiotensin-(1-7)

Recruiting Study Name: CREATE: Cross-tumoral Phase 2 With Crizotinib
Condition:
  • Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma
  • Locally Advanced and/or Me
    Date: 2012-01-24
    Interventions: Drug: Crizotinib (PF-02341066) For patients of 15yo and older, Capsules of 200 and 250 mg Daily dose of
Not yet recruiting Study Name: Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Condition:
  • Adrenal Cortex Carcinoma
  • Adult Alveolar Soft Part Sarcoma

  • Date: 2016-08-15
    Interventions:
    • Drug: Cabozantinib S-malate Gi
Next >>>